Lemaître Vascular Inc. Files DEF 14A for Executive Compensation
Ticker: LMAT · Form: DEF 14A · Filed: Apr 17, 2025 · CIK: 1158895
| Field | Detail |
|---|---|
| Company | Lemaitre Vascular Inc (LMAT) |
| Form Type | DEF 14A |
| Filed Date | Apr 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, sec-filing
TL;DR
Lemaître Vascular's DEF 14A is out, detailing exec pay and equity awards for 2024. Check it for compensation structure.
AI Summary
Lemaître Vascular Inc. filed its DEF 14A on April 17, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards, non-equity incentive plan compensation, and other compensation for its named executive officers. Specific details regarding the fair value of equity awards granted and vested are provided for the fiscal years 2020, 2021, and 2024.
Why It Matters
This filing provides shareholders with crucial information about how executive compensation is structured and awarded, impacting corporate governance and investor confidence.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures of executive compensation, but can sometimes reveal compensation practices that may be viewed favorably or unfavorably by investors.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for executive compensation details.)
- 20250417 — Filing Date (Date the DEF 14A was submitted to the SEC.)
- 20250602 — Period of Report (The period covered by the proxy statement.)
Key Players & Entities
- LEMAITRE VASCULAR INC (company) — Filer
- 0001158895 (company) — Central Index Key
- 3841 (dollar_amount) — Standard Industrial Classification
- 63 SECOND AVENUE (dollar_amount) — Business Address
- BURLINGTON (dollar_amount) — City
- MA (dollar_amount) — State
- 01803 (dollar_amount) — ZIP Code
- 781-221-2266 (dollar_amount) — Business Phone
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information regarding the company's annual meeting of stockholders and to disclose executive compensation details.
What fiscal year does the compensation information primarily cover?
The compensation information primarily covers the fiscal year ending December 31, 2024.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on April 17, 2025.
What is Lemaître Vascular Inc.'s Standard Industrial Classification code?
Lemaître Vascular Inc.'s Standard Industrial Classification code is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Where is Lemaître Vascular Inc. headquartered?
Lemaître Vascular Inc. is headquartered at 63 Second Avenue, Burlington, MA 01803.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 17, 2025 regarding LEMAITRE VASCULAR INC (LMAT).